Cargando…
Flavonoids Targeting Cancer Stem Cells for Augmenting Cancer Therapeutics
Cancer stem cells (CSC) have been identified in several types of solid tumors. In some cases, CSC may be the source of all the tumor cells, the cause of the tumor’s resistance to chemotherapeutic agents, and the source of metastatic cells. Thus, a combination therapy targeting non-CSC tumor cells as...
Autores principales: | Meerson, Ari, Khatib, Soliman, Mahajna, Jamal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657727/ https://www.ncbi.nlm.nih.gov/pubmed/34884848 http://dx.doi.org/10.3390/ijms222313044 |
Ejemplares similares
-
Flavonoids-Macromolecules Interactions in Human Diseases with Focus on Alzheimer, Atherosclerosis and Cancer
por: Atrahimovich, Dana, et al.
Publicado: (2021) -
2-Hydroxyestradiol Overcomes Mesenchymal Stem Cells-Mediated Platinum Chemoresistance in Ovarian Cancer Cells in an ERK-Independent Fashion
por: Khamaisi, Hazem, et al.
Publicado: (2022) -
Leptin and insulin up-regulate miR-4443 to suppress NCOA1 and TRAF4, and decrease the invasiveness of human colon cancer cells
por: Meerson, Ari, et al.
Publicado: (2016) -
Targeting Wnt/β-Catenin Pathway by Flavonoids: Implication for Cancer Therapeutics
por: Pandey, Pratibha, et al.
Publicado: (2023) -
Autophagy: Mechanisms and Therapeutic Potential of Flavonoids in Cancer
por: Pang, Xuening, et al.
Publicado: (2021)